Table 4: Serum lipid concentrations (mg/dL) at baseline (0 weeks) and at 2 and 4 weeks after initiation of the intervention and changes from the baseline in the control and plant stanol ester groups.

VariableControl group
()
Plant stanol ester group
()
Mean difference
between groups
(95% CI)

Total cholesterol
 0 weeks (mg/dL)−3.3 (−15.9 to 9.3)
 2 weeks (mg/dL)−16.0 (−28.6 to −3.3)
 4 weeks (mg/dL)−15.6 (−28.0 to −3.1)
 % change 2–0 weeks−5.7 (−9.2 to −2.1)
 % change 4–0 weeks−5.6 (−8.9 to −2.2)
LDL-cholesterol
 0 weeks (mg/dL)−3.8 (−16.2 to 8.6)
 2 weeks (mg/dL)−15.4 (−27.0 to −3.9)
 4 weeks (mg/dL)−16.5 (−27.9 to −5.2)
 % change 2–0 weeks−7.6 (−12.9 to −2.2)
 % change 4–0 weeks−9.0 (−13.4 to −4.6)
HDL-cholesterol
 0 weeks (mg/dL)−0.4 (−4.8 to 3.9)
 2 weeks (mg/dL)−2.1 (−6.6 to 2.4)
 4 weeks (mg/dL)−0.1 (−4.7 to 4.5)
 % change 2–0 weeks−2.9 (−6.8 to 1.0)
 % change 4–0 weeks0.5 (−4.1 to 5.2)
Triglycerides
 0 weeks (mg/dL)4.6 (−21.1 to 30.4)
 2 weeks (mg/dL)8.0 (−20.9 to 37.0)
 4 weeks (mg/dL)5.3 (−21.8 to 32.3)
 % change 2–0 weeks7.4 (−6.6 to 21.4)
 % change 4–0 weeks−0.1 (−14.6 to 14.5)

Data are presented as mean ± SD. difference between control and plant stanol ester groups (, independent samples t-test). difference compared to the baseline (, paired samples t-test).